Home > Boards > US OTC > Medical - Drugs > Creative Medical Technology Holdings, Inc. (CELZ)

“THOMAS ICHIM, PHD Thomas E. Ichim founded 5 companies,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Rk3 Member Profile
 
Followed By 27
Posts 1,346
Boards Moderated 0
Alias Born 09/22/11
160x600 placeholder
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 9/13/2019 4:46:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 4:02:24 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 8/30/2019 4:02:45 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 4:49:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/31/2019 12:33:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2019 4:02:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2019 11:34:57 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2019 11:32:16 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/28/2019 4:33:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2019 2:24:35 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/20/2019 2:27:14 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/20/2019 4:48:52 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2019 5:27:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 6:44:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2019 4:08:03 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 4:42:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/5/2019 5:20:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/19/2019 4:57:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/2/2019 8:02:16 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2018 5:05:38 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2018 4:42:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2018 5:46:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2018 5:29:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/18/2018 6:25:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/18/2018 6:23:04 PM
Rk3   Thursday, 08/08/19 02:03:16 PM
Re: None
Post # of 93697 
“THOMAS ICHIM, PHD
Thomas E. Ichim founded 5 companies, among them: ToleroTech Technology, Inc., MedVax Pharma Corp. and Biorasi LLC. Presently, Dr. Ichim holds the position of Director & Chief Scientific Officer at Nobilis Therapeutics, Inc., Chief Scientific Officer & Director at Creative Medical Technology Holdings, Inc., President & Director at Creative Medical Technologies, Inc. (a subsidiary of Creative Medical Technology Holdings, Inc.) and Director & Chief Scientific Officer at Batu Biologics, Inc. (which he founded in 2014). Dr. Ichim is also on the board of Therapeutic Solutions International, Inc. and Riordan Clinic and Director & Vice President at Creative Medical Health, Inc.
In the past Thomas E. Ichim was Director & Chief Scientific Officer at Regen Biopharma, Inc., Vice President-Cellular Therapies at Intrexon Corp. and President, Director & Chief Scientific Officer at Medistem, Inc. (a subsidiary of Intrexon Corp.) and Program Manager at Biorasi LLC (he founded the company in 2004).
He received a graduate degree from the University of Western Ontario, an undergraduate degree from The University of Waterloo and a doctorate from the University of Science, Arts & Technology.

https://regenerativeacademy.com/thomas-ichim/

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist